Install any skill in seconds. Free to start, no credit card required.
Get Started Free →Multi-omics integration — orchestrate per-layer analysis (transcriptomics, proteomics, epigenomics, genomics, metabolomics) then perform cross-omics correlation, multi-omics clustering, and pathway-level integration. Use for integrative systems-biology analysis, multi-modal disease characterization, and cross-omics biomarker discovery.
| Test case | Without → With | Effect | Δ tokens | Δ turns |
|---|---|---|---|---|
| case-12 | ✗→✓ | ▲ Improved | 48% | 0% |
| case-14 | ✗→✓ | ▲ Improved | 21% | 0% |
| case-15 | ✗→✓ | ▲ Improved | 24% | 0% |
| case-21 | ✗→✓ | ▲ Improved | 60% | 0% |
| case-04 | ✓→✓ | = Same ✓ | 61% | 0% |
Coordinate and integrate multiple omics datasets for comprehensive systems biology analysis. Orchestrates specialized ToolUniverse skills to perform cross-omics correlation, multi-omics clustering, pathway-level integration, and unified interpretation.
Multi-omics integration asks whether different molecular layers tell a concordant story. If a gene is upregulated in RNA-seq AND its protein is elevated in proteomics, that is concordant evidence of true biological change. Discordance — high mRNA but low protein, or elevated protein without matching mRNA — may indicate post-transcriptional regulation (miRNA silencing, protein degradation, translational control) and is itself a meaningful finding worth reporting. Not every discordance is noise; some are the most interesting biology.
ReactomeAnalysis_pathway_enrichment or gseapy on the actual gene lists; never list enriched pathways from memory.Phase 1: Data Loading & QC
Load each omics type, format-specific QC, normalize
Supported: RNA-seq, proteomics, methylation, CNV/SNV, metabolomics
Phase 2: Sample Matching
Harmonize sample IDs, find common samples, handle missing omics
Phase 3: Feature Mapping
Map features to common gene-level identifiers
CpG->gene (promoter), CNV->gene, metabolite->enzyme
Phase 4: Cross-Omics Correlation
RNA vs Protein (translation efficiency)
Methylation vs Expression (epigenetic regulation)
CNV vs Expression (dosage effect)
eQTL variants vs Expression (genetic regulation)
Phase 5: Multi-Omics Clustering
MOFA+, NMF, SNF for patient subtyping
Phase 6: Pathway-Level Integration
Aggregate omics evidence at pathway level
Score pathway dysregulation with combined evidence
Phase 7: Biomarker Discovery
Feature selection across omics, multi-omics classification
Phase 8: Integrated Report
Summary, correlations, clusters, pathways, biomarkersSee: phase_details.md for complete code and implementation details.
| Omics | Formats | QC Focus | |-------|---------|----------| | Transcriptomics | CSV/TSV, HDF5, h5ad | Low-count filter, normalize (TPM/DESeq2), log-transform | | Proteomics | MaxQuant, Spectronaut, DIA-NN | Missing value imputation, median/quantile normalization | | Methylation | IDAT, beta matrices | Failed probes, batch correction, cross-reactive filter | | Genomics | VCF, SEG (CNV) | Variant QC, CNV segmentation | | Metabolomics | Peak tables | Missing values, normalization |
pythondef match_samples_across_omics(omics_data_dict): """Match samples across multiple omics datasets.""" sample_ids = {k: set(df.columns) for k, df in omics_data_dict.items()} common_samples = set.intersection(*sample_ids.values()) matched_data = {k: df[sorted(common_samples)] for k, df in omics_data_dict.items()} return sorted(common_samples), matched_data
pythonfrom scipy.stats import spearmanr, pearsonr # RNA vs Protein: expect positive r ~ 0.4-0.6 # Methylation vs Expression: expect negative r (promoter repression) # CNV vs Expression: expect positive r (dosage effect) for gene in common_genes: r, p = spearmanr(rna[gene], protein[gene])
python# Score pathway dysregulation using combined evidence from all omics # Aggregate per-gene evidence, then per-pathway pathway_score = mean(abs(rna_fc) + abs(protein_fc) + abs(meth_diff) + abs(cnv))
See: phase_details.md for full implementations of each operation.
| Method | Description | Best For | |--------|-------------|----------| | MOFA+ | Latent factors explaining cross-omics variation | Identifying shared/omics-specific drivers | | Joint NMF | Shared decomposition across omics | Patient subtype discovery | | SNF | Similarity network fusion | Integrating heterogeneous data types |
| Skill | Used For | Phase | |-------|----------|-------| | tooluniverse-rnaseq-deseq2 | RNA-seq analysis | 1, 4 | | tooluniverse-epigenomics | Methylation, ChIP-seq | 1, 4 | | tooluniverse-variant-analysis | CNV/SNV processing | 1, 3, 4 | | tooluniverse-protein-interactions | Protein network context | 6 | | tooluniverse-gene-enrichment | Pathway enrichment | 6 | | tooluniverse-expression-data-retrieval | Public data retrieval | 1 | | tooluniverse-target-research | Gene/protein annotation | 3, 8 |
Integrate TCGA RNA-seq + proteomics + methylation + CNV to identify patient subtypes, cross-omics driver genes, and multi-omics biomarkers.
Identify SNP -> methylation -> expression regulatory chains (mediation analysis).
Predict drug response using baseline multi-omics profiles; identify resistance/sensitivity pathways.
See: phase_details.md "Use Cases" for detailed step-by-step workflows.
| Component | Requirement | |-----------|-------------| | Omics types | At least 2 datasets | | Common samples | At least 10 across omics | | Cross-correlation | Pearson/Spearman computed | | Clustering | At least one method (MOFA+, NMF, or SNF) | | Pathway integration | Enrichment with multi-omics evidence scores | | Report | Summary, correlations, clusters, pathways, biomarkers |
Other measured skills in the registry, with their headline benchmark lift.